IND, or the Investigational New Drug Application, is a U.S. permission process required to move any new medicine or therapy from laboratory research to human testing, meaning clinical trials. For example, imagine scientists have developed a new medicine. They cannot directly test it on humans. First, they must submit proof to the U.S. drug authority through an … Read more
Below is a summary of the 10 most frequently observed audit findings in pharmaceutical manufacturing plants, followed by detailed descriptions, examples, preventive strategies, and relevant industry keywords. Each issue is based on industry reports and regulatory inspection data. Common Audit Finding: 1. Documentation and Record-Keeping Deficiencies: Deficiencies in documentation and records, such as missing or … Read more
Understand and Differentiate them FDA Form 483 and Warning Letters: FDA Form 483 is like a detailed report card that talks about what people saw when they visited the manufacturing site. These people work for the FDA, and they write down everything they notice in a special order based on how important it is. Each … Read more
Laboratory Incident Definition: Any unintentional or unexpected event occurring during, discovered within, or arising after analysis that may adversely impact the quality of data and the resulting outcomes. Types of Common Laboratory Incidents: Below are the different common types of lab incidents in the pharmaceutical field that often occur. Type of Lab incident: Laboratory incidents … Read more
Understand ALCOA, ALCOA+, and ALCOA++ in pharma. GMP data integrity principles, FDA & EMA 2026 expectations, audit trails, and inspection-ready compliance explained.